Jpmorgan Chase & CO Tela Bio, Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TELA
# of Institutions
68Shares Held
20MCall Options Held
7.7KPut Options Held
1.1K-
Essex Woodlands Management, Inc. The Woodlands, TX4.11MShares$11.7 Million6.32% of portfolio
-
Orbimed Advisors LLC San Diego, CA2.46MShares$7 Million0.28% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.45MShares$6.97 Million0.77% of portfolio
-
Aigh Capital Management LLC Baltimore, MD1.66MShares$4.72 Million2.82% of portfolio
-
Paradigm Capital Management Inc1.26MShares$3.58 Million0.27% of portfolio
About TELA Bio, Inc.
- Ticker TELA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 19,157,600
- Market Cap $54.6M
- Description
- TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...